Logo

Asuragen's AmplideX PCR/CE C9orf72 Kit

Jul 06, 2016

Asuragen has launched the AmplideX PCR/CE C9orf72 Kit for research use. The PCR/capillary electrophoresis-based assay uses Asuragen's proprietary technology for analyzing high homology and GC-rich content. The kit provides clinical and pharmaceutical researchers with a method for high-resolution genotyping of hexanucleotide repeat expansions in C9orf72, a gene of emerging interest in frontotemporal dementia, the company said.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.